BioSouth was conceived and developed by a diverse group of industry professionals and academics with a shared commitment to developing a capability for biomanufacturing in Australasia to meet the demands of this rapidly expanding global industry.
Travis Glare
Formerly director of the Bio-Protection Research Centre and Professor of Applied Entomology at Lincoln University, Travis brings vast experience in precision fermentation and a proven track record in fermentation process design and the related engineering behind it.
William Wattie
Currently managing director of Astrea Group in Brazil, an advanced pet food ingredients manufacturer brings experience in greenfield site development and structuring international business partnerships. William looks after regulatory affairs and capital raising.
John Mead
John brings decades of experience in delivering on challenging processing plant builds throughout New Zealand, Australia and around the world. With experience in food and pharmaceutical plant design, installation and even to steady-state processing, John is taking the lead in building out BioSouth’s processing capacity.
SCIENCE ADVISORY GROUP
The Science Advisory Group (SAG) exists to support BioSouth and its customers with access to leading-edge science around precision fermentation, particularly in the area of biological pesticides.
The SAG is able to assess commercial and technical viability at the early stage of production development and advise BioSouth and its customers.
Dr Roma Gwynn, a founder and key shareholder in Rationale Biopesticide Strategists, Roma has expertise in facilitating the process of getting biopesticide products into the market and with a particular focus on process efficiency.
Lionel Henderson, formerly of CSIRO, Lionel has extensive experience in start-ups in the precision fermentation space, as well as commercialisation of innovative technologies.
Dr Ian Boddy, an independent business consultant, Ian brings decades of experience in both chemical and biopesticide product development.
Prof Emily Parker, head of the Ferrier Institute at Victoria University of Wellington, Emily is a globally recognised leader in biomedical research and synthetic biology.